These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36059652)

  • 1. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.
    Chen S; Li Z; Wang Y; Fan S
    Front Oncol; 2022; 12():952425. PubMed ID: 36059652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS/MAPK pathway via interacting with RPS3A.
    Li Z; Zhang M; Chen S; Dong W; Zong R; Wang Y; Fan S
    Cell Signal; 2023 Dec; 112():110914. PubMed ID: 37806541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer.
    Cheng X; Ma T; Yi L; Su C; Wang X; Wen T; Wang B; Wang Y; Zhang H; Liu Z
    Ann Transl Med; 2021 Mar; 9(6):478. PubMed ID: 33850875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA small nucleolar RNA host gene 1 knockdown suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating microRNA-424-5p/FGF2
    Li Z; Wang X; Liang S
    Exp Ther Med; 2021 Apr; 21(4):325. PubMed ID: 33732298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Duan H; Li X; Chen Y; Wang Y; Li Z
    Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.
    Feng L; Liao WX; Luo Q; Zhang HH; Wang W; Zheng J; Chen DB
    J Cell Physiol; 2012 Jun; 227(6):2480-91. PubMed ID: 21830216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.
    Li C; Yu S; Wu S; Ni Y; Pan Z
    Onco Targets Ther; 2019; 12():5311-5322. PubMed ID: 31371979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3.
    Liu D; Lu Q; Wang X; Wang J; Lu N; Jiang Z; Hao X; Li J; Liu J; Cao P; Peng G; Tao Y; Zhao D; He F; Tang L
    Cell Res; 2019 May; 29(5):365-378. PubMed ID: 30858559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors.
    Chen S; Li Z; Huang W; Wang Y; Fan S
    J Cancer; 2021; 12(15):4505-4512. PubMed ID: 34149914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades.
    Siu MKY; Jiang YX; Wang JJ; Leung THY; Han CY; Tsang BK; Cheung ANY; Ngan HYS; Chan KKL
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
    Zhang D; Qiu S; Wang Q; Zheng J
    Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.
    Wang K; Jiang YZ; Chen DB; Zheng J
    Placenta; 2009 Dec; 30(12):1045-51. PubMed ID: 19892399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.
    Xu M; Tian GL; Hao CC; Shi M; Zha DJ; Liang K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5215-5222. PubMed ID: 31298371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2.
    Fu XF; Zhao HC; Yang CL; Chen CZ; Wang K; Gao F; Tian YZ; Zhao HL
    Oncol Lett; 2021 Aug; 22(2):626. PubMed ID: 34267818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells.
    Huang YS; Wang TX; Lin XM; Wang H; Li RZ; Zeng X; Zhu C; Chen LK; Guo Q; Liu H; Wu XP
    Anticancer Drugs; 2019 Nov; 30(10):973-982. PubMed ID: 31503014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
    Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway.
    Li J; Yang C; Yang J; Zou L
    Cancer Manag Res; 2019; 11():7439-7453. PubMed ID: 31496803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Li R; Wang Y; Xu Y; He X; Li Y
    Int J Oncol; 2019 Nov; 55(5):1110-1124. PubMed ID: 31545411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.